Macrolide Suspension BE [Study Per­for­mance]

posted by mayur661 – India, 2010-06-03 07:38 (5871 d 10:54 ago) – Posting: # 5420
Views: 6,081

❝ Please give more information: study design, dose, formulation differences?


Two way cross over design

200 mg/5mL

No iffrence in formulation only API have diffrent hydrate form other than refrence

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
307 visitors (0 registered, 307 guests [including 21 identified bots]).
Forum time: 18:32 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5